Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6748)
All Articles published online
|
Publishing Process of This Article
|
May 26, 2020 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yan LN, Zhang X, Xu F, Fan YY, Ge B, Guo H, Li ZL. Four-microRNA signature for detection of type 2 diabetes. World J Clin Cases 2020; 8(10): 1923-1931 [PMID: 32518782 DOI: 10.12998/wjcc.v8.i10.1923] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v8/i10/1923.htm |
| Number | Citing Articles |
| 1 |
Kanika Suri, Jason A. Bubier, Michael V. Wiles, Leonard D. Shultz, Mansoor M. Amiji, Vishnu Hosur. Role of MicroRNA in Inflammatory Bowel Disease: Clinical Evidence and the Development of Preclinical Animal Models. Cells 2021; 10(9): 2204 doi: 10.3390/cells10092204
|
| 2 |
María Victoria Mencucci, Ana María Rojas-Mendoza, Eduardo Andrés-León, Carolina Lisi Román, Juan José Gagliardino, Martín Carlos Abba, Bárbara Maiztegui. Identification of novel microRNAs associated with type 2 diabetes by an integrative bioinformatic analysis. Human Gene 2022; 34: 201125 doi: 10.1016/j.humgen.2022.201125
|
| 3 |
Ilhaam Ayaz Durrani, Attya Bhatti, Peter John. Regulatory MicroRNAs in T2DM and Breast Cancer. Processes 2021; 9(5): 819 doi: 10.3390/pr9050819
|
| 4 |
Mohammad Reza Afsharmanesh, Zeinab Mohammadi, Azad Reza Mansourian, Seyyed Mehdi Jafari. A Review of micro RNAs changes in T2DM in animals and humans. Journal of Diabetes 2023; 15(8): 649 doi: 10.1111/1753-0407.13431
|
| 5 |
Ya-Ke Lu, Xi Chu, Shuo Wang, Yue Sun, Jie Zhang, Jing Dong, Yu-Xiang Yan. Identification of Circulating hsa_circ_0063425 and hsa_circ_0056891 as Novel Biomarkers for Detection of Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism 2021; 106(7): e2688 doi: 10.1210/clinem/dgab101
|
| 6 |
Felipe Padilla-Martinez, Gladys Wojciechowska, Lukasz Szczerbinski, Adam Kretowski. Circulating Nucleic Acid-Based Biomarkers of Type 2 Diabetes. International Journal of Molecular Sciences 2021; 23(1): 295 doi: 10.3390/ijms23010295
|
| 7 |
Weronika Kraczkowska, Lucyna Stachowiak, Andrzej Pławski, Paweł Piotr Jagodziński. Circulating miRNA as potential biomarkers for diabetes mellitus type 2: should we focus on searching for sex differences?. Journal of Applied Genetics 2022; 63(2): 293 doi: 10.1007/s13353-021-00678-5
|
| 8 |
Bartosz Walkowski, Marcin Kleibert, Miłosz Majka, Małgorzata Wojciechowska. Insight into the Role of the PI3K/Akt Pathway in Ischemic Injury and Post-Infarct Left Ventricular Remodeling in Normal and Diabetic Heart. Cells 2022; 11(9): 1553 doi: 10.3390/cells11091553
|
| 9 |
Angel Mendonca, Prabu Thandapani, Priyashree Nagarajan, Sanjana Venkatesh, Sujatha Sundaresan. Role of microRNAs in regulation of insulin secretion and insulin signaling involved in type 2 diabetes mellitus. Journal of Biosciences 2022; 47(4) doi: 10.1007/s12038-022-00295-2
|
| 10 |
Elnaz Ghoreishi, Seyedeh Zahra Shahrokhi, Faranak Kazerouni, Ali Rahimipour. Circulating miR-148b-3p and miR-27a-3p can be potential biomarkers for diagnosis of pre-diabetes and type 2 diabetes: integrating experimental and in-silico approaches. BMC Endocrine Disorders 2022; 22(1) doi: 10.1186/s12902-022-01120-5
|
| 11 |
Chioma Odimegwu, Samuel Uwaezuoke, Ugo Chikani, Ngozi Mbanefo, Ken Adiele, Charles Nwolisa, Chizoma Eneh, Chibuzo Ndiokwelu, Somkenechi Okpala, Francis Ogbuka, Kenneth Odo, Ijeoma Ohuche, Chinelo Obiora-Izuka. Targeting the Epigenetic Marks in Type 2 Diabetes Mellitus: Will Epigenetic Therapy Be a Valuable Adjunct to Pharmacotherapy?. Diabetes, Metabolic Syndrome and Obesity 2024; : 3557 doi: 10.2147/DMSO.S479077
|
| 12 |
Miłosz Majka, Marcin Kleibert, Małgorzata Wojciechowska. Impact of the Main Cardiovascular Risk Factors on Plasma Extracellular Vesicles and Their Influence on the Heart’s Vulnerability to Ischemia-Reperfusion Injury. Cells 2021; 10(12): 3331 doi: 10.3390/cells10123331
|
| 13 |
Khaoula Errafii, Amin Jayyous, Abdelillah Arredouani, Hasan Khatib, Fouad Azizi, Ramzi M. Mohammad, Muhammad Abdul-Ghani, Mohamed Chikri. Comprehensive analysis of circulating miRNA expression profiles in insulin resistance and type 2 diabetes in Qatari population. All Life 2022; 15(1): 191 doi: 10.1080/26895293.2022.2033853
|
| 14 |
Guang Yang, Jinxin Shi. miRNA-130a-3p targets sphingosine-1-phosphate receptor 1 to activate the microglial and astrocytes and to promote neural injury under the high glucose condition. Open Medicine 2022; 17(1): 2117 doi: 10.1515/med-2022-0565
|
| 15 |
Joanna Szydełko, Beata Matyjaszek-Matuszek. MicroRNAs as Biomarkers for Coronary Artery Disease Related to Type 2 Diabetes Mellitus—From Pathogenesis to Potential Clinical Application. International Journal of Molecular Sciences 2022; 24(1): 616 doi: 10.3390/ijms24010616
|
| 16 |
Hsiuying Wang. MicroRNAs, Parkinson’s Disease, and Diabetes Mellitus. International Journal of Molecular Sciences 2021; 22(6): 2953 doi: 10.3390/ijms22062953
|
| 17 |
Constantine E Kosmas, Andreas Sourlas, Konstantinos Oikonomakis, Eleni-Angeliki Zoumi, Aikaterini Papadimitriou, Christina E Kostara. Biomarkers of insulin sensitivity/resistance. Journal of International Medical Research 2024; 52(10) doi: 10.1177/03000605241285550
|
| 18 |
Marianna ABATE, Amalia LUCE, Alessia M. COSSU, Marianna SCRIMA, Gabriella MISSO, Michele CARAGLIA, Silvia ZAPPAVIGNA. Molecular markers as a new tool for diagnostic and prognostic definition of type 2 diabetes mellitus. Minerva Medica 2023; 113(6) doi: 10.23736/S0026-4806.22.08315-X
|